Circulating microRNA profile in response to remdesivir treatment in coronavirus disease 2019 (COVID-19) patients

Coronavirus disease 2019 (COVID-19), a serious infectious disease caused by the recently discovered severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has caused a major global health crisis. Although no specific antiviral drugs have been proven to be fully effective against COVID-19, rem...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Archives of virology 2023-07, Vol.168 (7), p.194-194, Article 194
Hauptverfasser:	Fayyad-Kazan, Mohammad, Makki, Rawan, Homsi, Mahmoud El, Samadi, Ahmad, Chaaban, Hilal, Majzoub, Rania El, Hamade, Eva, Fayyad-Kazan, Hussein, Badran, Bassam
Format:	Artikel
Sprache:	eng
Schlagworte:	Antiviral agents Antiviral drugs Bioinformatics biomarkers Biomedical and Life Sciences Biomedicine Biosynthesis Circulating MicroRNA Coronaviruses COVID-19 COVID-19 Drug Treatment COVID-19 infection Glycosaminoglycans Humans Infectious Diseases Medical Microbiology microRNA MicroRNAs MicroRNAs - genetics miRNA Molecular modelling Nucleoside analogs nucleosides Original Article Public health Remission Remission (Medicine) SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2 therapeutics Transforming growth factor-b Virology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!